POLIVY

all catalysts(0)

nothing on the calendar yet

News(2)

• Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio
  Through its DualityBio deal, Roche's Genentech hopes to create antibody-drug conjugates with payloads that can circumvent growing cancer drug resistance.
  biospace · 1mo ago
• Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
  Roche has 19 investigational medicines that could launch by 2030—and even if not all of them make it to market, the company is “well set-up for growth into the next decade,” CEO Thomas Schinecker s…
  biospace · 2mo ago